Specifically, the protein product of PRKCI, PKCι, is overexpressed in a large percent of lung and ovarian cancers where high PKCι expression predicts poor survival, and disruption of PKCι signaling blocks cancer cell transformed growth and tumor formation [13,15,16,17,18]. The gene discussed is PRKCI; the disease is ovarian carcinoma.